These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28771721)

  • 1. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
    Zhao L; Zhang P; Su XJ; Zhang B
    J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
    Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
    IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL; Ren SN; Cao H; Tian XF
    IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
    Sun Y; Jia X; Gao Q; Liu X; Hou L
    IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
    Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
    J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.
    Qin S; Li Y; Cao X; Du J; Huang X
    Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27884977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradation.
    Tian H; Lian R; Li Y; Liu C; Liang S; Li W; Tao T; Wu X; Ye Y; Yang X; Han J; Chen X; Li J; He Y; Li M; Wu J; Cai J
    Nat Commun; 2020 Oct; 11(1):5127. PubMed ID: 33046716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
    Yi BR; Kim TH; Kim YS; Choi KC
    Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
    Ping H; Guo L; Xi J; Wang D
    Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial-mesenchymal transition in non-small cell lung cancer cells.
    Li CH; Liu CW; Tsai CH; Peng YJ; Yang YH; Liao PL; Lee CC; Cheng YW; Kang JJ
    Arch Toxicol; 2017 May; 91(5):2165-2178. PubMed ID: 27752740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDC1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transition.
    Liu X; Dong R; Jiang Z; Wei Y; Li Y; Wei L; Sun H; Li Y; Yang N; Yang Q; Liu Z; Kong B
    Tumour Biol; 2015 Jun; 36(6):4261-9. PubMed ID: 25592380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CHIP promotes ovarian cancer metastasis by inducing Snail-mediated epithelial-mesenchymal transition.
    Park SM; Park SH; Ryu KJ; Kim IK; Han H; Kim HJ; Kim SH; Hong KS; Kim H; Kim M; Cho BI; Heo JD; Kim NH; Hwang EM; Park JY; Yook JI; Cho HJ; Hwangbo C; Kim KD; Song H; Yoo J
    Mol Oncol; 2019 May; 13(5):1280-1295. PubMed ID: 30927556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRABP2 accelerates epithelial mesenchymal transition in serous ovarian cancer cells by promoting TRIM16 methylation via upregulating EZH2 expression.
    Xie T; Tan M; Gao Y; Yang H
    Environ Toxicol; 2022 Aug; 37(8):1957-1967. PubMed ID: 35442568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling.
    Yang Y; Hao X; Zhang J; Gao T; Huo M; Liu W; Hu T; Ma T; Yuan B; Zhang M; Teng X; Yu H; Huang W; Wang Y
    Cancer Lett; 2024 Sep; 600():217157. PubMed ID: 39127340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the recognition and degradation of host TRIM proteins by Salmonella effector SopA.
    Fiskin E; Bhogaraju S; Herhaus L; Kalayil S; Hahn M; Dikic I
    Nat Commun; 2017 Jan; 8():14004. PubMed ID: 28084320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human NANOS3 gene contributes to lung tumour invasion by inducing epithelial-mesenchymal transition.
    Grelet S; Andries V; Polette M; Gilles C; Staes K; Martin AP; Kileztky C; Terryn C; Dalstein V; Cheng CW; Shen CY; Birembaut P; Van Roy F; Nawrocki-Raby B
    J Pathol; 2015 Sep; 237(1):25-37. PubMed ID: 25904364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling.
    Chen Y; Zhao J; Li D; Hao J; He P; Wang H; Zhang M
    Yonsei Med J; 2018 Jan; 59(1):43-50. PubMed ID: 29214775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.